cbdMD, Inc.

cbdMD, Inc. is a wellness company based in Charlotte, North Carolina, specializing in the production and distribution of hemp-derived cannabinoid products and related functional wellness brands. The company's mission is to enhance people's overall quality of life through innovative, natural products developed and manufactured under industry-leading standards, with a strong focus on CBD education, awareness, accessibility, and consumer advocacy. They aim to be a trusted authority in health and wellness, delivering high-quality, health-focused products.

The company's diverse product portfolio includes CBD tinctures, gummies, topicals, capsules, bath bombs, and sleep aids under its flagship cbdMD brand. Additionally, cbdMD, Inc. offers veterinarian-formulated CBD products for pets through its Paw CBD brand, functional mushroom supplements under ATRx Labs, and hemp-derived THC beverages with the Herbal Oasis brand. Products are available in both broad-spectrum (THC below detection) and full-spectrum formulations, distributed via direct-to-consumer e-commerce, wholesalers, and brick-and-mortar retailers.

Led by CEO and CFO Ronan Kennedy, who assumed the interim CEO role in March 2023 and joined the Board of Directors in December 2024, cbdMD, Inc. has focused on strategic initiatives to stabilize its core business and expand into higher-growth, federally compliant product categories. Recent developments include the acquisition of Bluebird Botanicals in January 2026, which bolstered its revenue base and regulatory compliance. The company also reported sequential revenue growth and improved liquidity in Q1 FY2026 and launched a clinical healthcare channel in April 2026 to support a federal pathway for hemp-derived CBD in Medicare.